Treatment options for genetically determined immunodeficiency
- 1 February 2003
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 361 (9357) , 541-542
- https://doi.org/10.1016/s0140-6736(03)12562-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene TherapyNew England Journal of Medicine, 2002
- Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survivalBlood, 2002
- Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in childrenBone Marrow Transplantation, 2001
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1999
- LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processesGenes & Development, 1998
- Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cellsBlood, 1983
- Severe Combined Immunodeficiency DiseasePublished by American Medical Association (AMA) ,1977
- IMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCYThe Lancet, 1968
- BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROMEThe Lancet, 1968